<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//oncopeptides.com.haus.se/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/</loc>
		<lastmod>2026-03-26T13:03:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-med-cristina-bando-landschef-for-spanien/</loc>
		<lastmod>2026-03-26T13:03:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-featuring-cristina-bando-spanish-country-manager/</loc>
		<lastmod>2026-03-26T13:03:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-real-worlddata-och-fragor-fran-investerare/</loc>
		<lastmod>2026-03-24T09:22:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-real-world-data-and-questions-from-investors/</loc>
		<lastmod>2026-03-24T09:20:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-en-blandad-kompott-av-amnen/</loc>
		<lastmod>2026-03-06T10:09:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-addressing-your-q3-questions/</loc>
		<lastmod>2026-02-27T14:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-q1-sales-and-mena-partnership/</loc>
		<lastmod>2026-02-27T14:21:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-first-edition/</loc>
		<lastmod>2026-02-27T14:06:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-abandon-type-ii-variation-process-and-price-in-germany/</loc>
		<lastmod>2026-02-27T14:03:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-medical-congresses-and-marketing-and-sales/</loc>
		<lastmod>2026-02-27T13:58:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-end-of-the-year-2023/</loc>
		<lastmod>2026-02-27T13:55:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-q3-earnings/</loc>
		<lastmod>2026-02-27T13:54:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-the-treatment-landscape-and-competition/</loc>
		<lastmod>2026-02-27T13:47:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-the-recent-fda-decision/</loc>
		<lastmod>2026-02-27T13:45:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-the-companys-rights-issue/</loc>
		<lastmod>2026-02-27T13:43:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-spain-visit-rights-issue-and-next-week/</loc>
		<lastmod>2026-02-27T13:36:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-congresses-and-cd-selection/</loc>
		<lastmod>2026-02-27T13:34:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-south-korea-growth-and-pipeline/</loc>
		<lastmod>2026-02-27T13:28:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-with-special-guest-patrick-jordan-and-talk-about-mm-day-in-europe/</loc>
		<lastmod>2026-02-27T13:26:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-reimbursement-in-italy/</loc>
		<lastmod>2026-02-27T13:19:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-end-of-year-2024/</loc>
		<lastmod>2026-02-27T13:17:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-meet-the-italian-team/</loc>
		<lastmod>2026-02-27T13:16:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-looking-into-2025/</loc>
		<lastmod>2026-02-26T17:03:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-first-order-in-italy-and-q4-report/</loc>
		<lastmod>2026-02-26T17:01:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-a-mixed-bag-of-topics/</loc>
		<lastmod>2026-02-26T16:59:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-q1-and-comy/</loc>
		<lastmod>2026-02-26T15:31:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-commercialization-pipeline-and-ash/</loc>
		<lastmod>2026-02-26T14:48:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-the-first-half-of-2025-and-a-look-into-the-future/</loc>
		<lastmod>2026-02-24T17:41:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-on-eha-emn-guideline-inclusion/</loc>
		<lastmod>2026-02-24T17:39:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-about-rights-issue-europe-and-ims/</loc>
		<lastmod>2026-02-24T17:38:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/oncopeptalks/oncopeptalks-about-the-q4-report-2025-rights-issue-and-pipeline-news/</loc>
		<lastmod>2026-02-24T17:32:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-q4-rapporten-2025-foretradesemissionen-och-pipeline-nyheter/</loc>
		<lastmod>2026-02-23T17:29:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-kommersialisering-pipeline-och-ash/</loc>
		<lastmod>2025-12-16T17:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-emissionen-europa-och-ims/</loc>
		<lastmod>2025-09-11T14:53:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-inkludering-i-eha-emn-riktlinjer/</loc>
		<lastmod>2025-07-08T17:38:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-forsta-halvaret-2025-och-en-blick-in-i-framtiden/</loc>
		<lastmod>2025-07-04T17:40:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-q1-och-comy/</loc>
		<lastmod>2025-05-16T14:49:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-forsta-bestallningen-i-italien-och-q4-rapporten/</loc>
		<lastmod>2025-03-13T16:59:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-en-titt-pa-2025/</loc>
		<lastmod>2025-01-22T17:02:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-2024-i-backspegeln/</loc>
		<lastmod>2024-12-19T13:02:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-mot-det-italienska-teamet/</loc>
		<lastmod>2024-12-04T13:12:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-ersattning-i-italien/</loc>
		<lastmod>2024-11-27T13:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-svar-pa-era-fragor-om-q3/</loc>
		<lastmod>2024-11-12T13:22:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-med-gasten-patrick-jordan-och-samtal-om-mm-dagen-i-europa/</loc>
		<lastmod>2024-10-11T13:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-sydkorea-tillvaxt-och-pipeline/</loc>
		<lastmod>2024-09-12T13:26:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-kongresser-och-cd-urval/</loc>
		<lastmod>2024-06-27T13:29:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-spanienbesok-nyemission-och-nasta-vecka/</loc>
		<lastmod>2024-05-22T13:34:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-nettoforsaljning-q1-och-partnerskap-i-mena/</loc>
		<lastmod>2024-04-04T13:41:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-bolagets-foretradesemission/</loc>
		<lastmod>2024-03-13T13:41:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-det-senaste-fda-beslutet/</loc>
		<lastmod>2024-02-27T13:43:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-behandlingslandskapet-och-konkurrensen/</loc>
		<lastmod>2024-01-29T13:45:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-arssammanfattning-2023/</loc>
		<lastmod>2023-12-20T13:50:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-q3-resultat/</loc>
		<lastmod>2023-11-15T13:51:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://oncopeptides.com.haus.se/sv/oncopeptalks/oncopeptalks-om-medicinska-kongresser-och-marknadsforing-och-forsaljning/</loc>
		<lastmod>2023-10-20T13:55:26+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->